Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Protalex will continue a placebo-controlled, U.S. and South African Phase Ib trial of weekly
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury